Chen (Michael) Chen currently holds the position of Vice President and Head of Business Development at Simcere Pharmaceutical Group, leading the Business Development and Alliance Management team for China and the Asia-Pacific region since July 2022. Simultaneously, Chen serves as Vice President and Head of Business Development at Akeso, Inc. and has been with Merck KGaA since April 2016 in various capacities including Head of External Innovation for both APAC and China. Previous roles include Directorship at Raymoon Capital Ltd. focused on VC investment in biopharmaceuticals, Associate Director of Project Management and Business Development at WuXi AppTec managing significant projects for global pharmaceutical clients, and senior scientific roles at Spirogen Ltd. with a focus on antibody development. Chen holds a Ph.D. in Antibody Therapeutics from Imperial College London, alongside a Master’s in Cancer and Immunotherapy from the University of Nottingham and a Bachelor’s in Cell and Molecular Biology from the University of Essex.
This person is not in the org chart
This person is not in any teams
This person is not in any offices